Fed. Circ. Urged To Revive 'Inventive' DNA Patent
Genetic Technologies Ltd. urged a Federal Circuit panel Monday to revive a DNA technology patent successfully challenged by Bristol-Myers Squibb Co. for claiming a process found in nature, arguing the patent includes...To view the full article, register now.
Already a subscriber? Click here to view full article